Phase I study of safety and pharmacokinetics of a human anticytomegalovirus monoclonal antibody in allogeneic bone marrow transplant recipients.

W R Drobyski; M Gottlieb; D Carrigan; L Ostberg; M Grebenau; H Schran; P Magid; P Ehrlich; P I Nadler; R C Ash

doi:10.1097/00007890-199106000-00009

Phase I study of safety and pharmacokinetics of a human anticytomegalovirus monoclonal antibody in allogeneic bone marrow transplant recipients.

Identifier:nobleid.org/w1/20260515/3AF3C884

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/3AF3C884.svg?ark=w1%2F20260515%2F3AF3C884)](https://nobleid.org/work/w1/20260515/3AF3C884)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Phase I study of safety and pharmacokinetics of a human anticytomegalovirus monoclonal antibody in allogeneic bone marrow transplant recipients.

Identifier:nobleid.org/w1/20260515/3AF3C884

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/3AF3C884.svg?ark=w1%2F20260515%2F3AF3C884)](https://nobleid.org/work/w1/20260515/3AF3C884)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work